Eye Drops Lubricating Tears

Product NDC
55651-026
11-digit product format
556510026
Labeler code
55651
Product ID
55651-026_584b030c-552a-499d-95b1-9ff4c07fe0d1
Type
HUMAN OTC DRUG
Nonproprietary name
Hypromellose, Glycerin, Polyethylene glycol 400
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Labeler
KC Pharmaceuticals, Inc.
Application
part349
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2008-05-12
Marketing end
0000-00-00
Substance
HYPROMELLOSES; GLYCERIN; POLYETHYLENE GLYCOL 400
Active strength
2 mg/mL; mg/mL; mg/mL
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct55651-026DDiscontinued by firm2026-10-05
excluded packagepackage55651-02655651-026-01DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage55651-026-01d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage55651-026-01f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage55651-026-012ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage55651-026-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage55651-026-01cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage55651-026-01cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage55651-026-01302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage55651-026-01ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage55651-026-010efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage55651-026-01ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage55651-026-01367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage55651-026-01557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GLYCERINACTIVE INGREDIENTPDC6A3C0OXEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
HYPROMELLOSESACTIVE INGREDIENT3NXW29V3WOEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
GLYCERINACTIVE MOIETYPDC6A3C0OXEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
HYPROMELLOSESACTIVE MOIETY3NXW29V3WOEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W7EYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
DEXTROSEINACTIVE INGREDIENTIY9XDZ35W2EYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
POTASSIUM CHLORIDEINACTIVE INGREDIENT660YQ98I10EYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
SODIUM BICARBONATEINACTIVE INGREDIENT8MDF5V39QOEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULREYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
SODIUM PHOSPHATE, DIBASIC ANHYDROUSINACTIVE INGREDIENT22ADO53M6FEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEINACTIVE INGREDIENT593YOG76RNEYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2
WATERINACTIVE INGREDIENT059QF0KO0REYE DROPS LUBRICATING TEARS (HYPROMELLOSE, GLYCERIN, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC.]2